Product image of Niquitin Mini (Nicotine) supplied by GNH India

Niquitin Mini

Active Ingredient:
Nicotine
Origin:
EU

Niquitin Mini (Nicotine)

Nicotine, the active ingredient in Niquitin Mini, is a nicotine replacement therapy presented as an oral formulation for oral use. It helps adults who want to quit smoking by reducing nicotine withdrawal symptoms and cravings.

GNH India supplies Niquitin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability, regulatory compliance, and dedicated technical support throughout the supply chain.

Manufacturer / TM Owner

Omega Pharma A.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Niquitin Mini, a nicotine replacement therapy, supports smoking cessation by alleviating nicotine withdrawal.

  • Smoking cessation: helps reduce cravings and withdrawal symptoms, facilitating quitting.
  • Craving reduction: provides a controlled nicotine dose to lessen urge to smoke.
  • Relapse prevention: assists in maintaining abstinence after initial quitting.

How It Works

  • Nicotine acts as an agonist at nicotinic acetylcholine receptors in the central nervous system. By stimulating these receptors, it mimics the pharmacologic effects of tobacco‑derived nicotine, thereby reducing the intensity of withdrawal and cravings. The oral formulation delivers nicotine systemically, achieving steady plasma concentrations that ease the transition away from smoking while avoiding the harmful combustion products of tobacco, and supporting the overall cessation effort.

Side Effects

Common and serious adverse reactions may occur with oral nicotine therapy.

Common Side Effects

  • Nausea: mild stomach upset often reported.
  • Mouth irritation: soreness or tingling in the oral cavity.
  • Hiccups: transient episodes after dosing.
  • Dizziness: light‑headed sensation, usually brief.
  • Headache: mild to moderate intensity.
  • Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects

  • Arrhythmia: irregular heart rhythm requiring medical attention.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Chest pain: possible indication of cardiovascular strain.
  • Hypertension: elevated blood pressure episodes.
  • Seizures: rare neurologic events.
  • Persistent vomiting: may lead to dehydration.

Precautions & Warnings

Before using Niquitin Mini, consider the following precautions to ensure safe and effective therapy.

  • Assess cardiovascular status: patients with recent heart disease should use under medical supervision.
  • Evaluate psychiatric history: nicotine may exacerbate anxiety or mood disorders.
  • Review concomitant nicotine use: avoid combining with other nicotine products to prevent overdose.
  • Monitor blood pressure: nicotine can raise blood pressure in susceptible individuals.
  • Advise on proper dosing: follow prescriber instructions and do not exceed recommended amount.
  • Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Avoid Interactions

Niquitin Mini can interact with other medicines; awareness of major and moderate interactions helps prevent adverse effects.

Major Interactions (Avoid)

  • Other nicotine products: concurrent use may cause nicotine toxicity.
  • CYP2A6 inhibitors (e.g., methoxsalen): can increase nicotine plasma levels.
  • Monoamine oxidase inhibitors: may enhance cardiovascular stimulation.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: nicotine‑induced tachycardia may be masked.
  • Antidepressants (SSRIs): increased risk of insomnia or agitation.
  • Antihypertensive agents: nicotine may reduce their efficacy.
  • Caffeine: combined stimulant effect may increase jitteriness.
  • Alcohol: may intensify nicotine’s cardiovascular effects.

Frequently Asked Questions

Niquitin Mini is an oral nicotine replacement product used to help adults quit smoking. It provides a controlled dose of nicotine to lessen cravings and withdrawal symptoms, supporting the process of smoking cessation.

Nicotine in Niquitin Mini binds to nicotinic acetylcholine receptors in the brain, producing a mild stimulant effect that mimics the action of tobacco‑derived nicotine. This reduces the intensity of withdrawal and helps the user manage cravings while they stop smoking.

The appropriate dose of Niquitin Mini is determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and overall health. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for nicotine replacement therapy in pregnancy and lactation are limited. The product’s pregnancy category is unknown, so it should only be used if the potential benefit outweighs the risk and after consultation with a qualified healthcare provider.

To order Niquitin Mini, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Niquitin Mini delivers nicotine orally, offering a convenient alternative to patches, gum, or lozenges. Compared with patches, it provides a faster onset of action but requires dosing at specific intervals. Unlike gum, it does not require chewing, which some users find more comfortable.

Store Niquitin Mini at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and keep it out of reach of children.

Niquitin Mini is taken orally. The tablet or lozenge is swallowed with water as directed by the prescriber. It should be used according to the dosing schedule provided by the healthcare professional.

Serious risks include arrhythmia, severe allergic reactions (such as rash, swelling, or breathing difficulty), chest pain, hypertension, seizures, and persistent vomiting. Any of these symptoms require immediate medical attention.

Individuals with known hypersensitivity to nicotine, recent myocardial infarction, uncontrolled hypertension, or severe cardiovascular disease should avoid Niquitin Mini unless a physician determines it is safe. Pregnant or breastfeeding women should consult a healthcare professional before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT